Molecular Partners AG (MOLN)
6.12
+0.76
(+14.18%)
USD |
NASDAQ |
Nov 01, 16:00
6.15
+0.03
(+0.49%)
After-Hours: 20:00
Molecular Partners Price to Book Value: 1.174 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.174 |
| October 31, 2024 | 1.028 |
| October 30, 2024 | 1.179 |
| October 29, 2024 | 1.189 |
| October 28, 2024 | 1.239 |
| October 25, 2024 | 1.244 |
| October 24, 2024 | 1.154 |
| October 23, 2024 | 1.087 |
| October 22, 2024 | 1.260 |
| October 21, 2024 | 1.30 |
| October 18, 2024 | 0.9338 |
| October 17, 2024 | 0.9549 |
| October 16, 2024 | 0.9491 |
| October 15, 2024 | 0.9491 |
| October 14, 2024 | 0.9108 |
| October 11, 2024 | 0.9108 |
| October 10, 2024 | 0.9108 |
| October 09, 2024 | 0.9407 |
| October 08, 2024 | 0.9407 |
| October 07, 2024 | 0.9127 |
| October 04, 2024 | 0.9625 |
| October 03, 2024 | 0.8782 |
| October 02, 2024 | 0.8878 |
| October 01, 2024 | 0.9185 |
| September 30, 2024 | 0.9754 |
| Date | Value |
|---|---|
| September 27, 2024 | 0.9721 |
| September 26, 2024 | 0.8993 |
| September 25, 2024 | 0.8858 |
| September 24, 2024 | 0.9616 |
| September 23, 2024 | 0.9069 |
| September 20, 2024 | 0.8954 |
| September 19, 2024 | 0.8954 |
| September 18, 2024 | 0.928 |
| September 17, 2024 | 0.974 |
| September 16, 2024 | 0.999 |
| September 13, 2024 | 1.001 |
| September 12, 2024 | 1.060 |
| September 11, 2024 | 1.055 |
| September 10, 2024 | 1.076 |
| September 09, 2024 | 1.078 |
| September 06, 2024 | 1.056 |
| September 05, 2024 | 1.109 |
| September 04, 2024 | 1.134 |
| September 03, 2024 | 1.081 |
| August 30, 2024 | 1.089 |
| August 29, 2024 | 1.242 |
| August 28, 2024 | 1.214 |
| August 27, 2024 | 1.327 |
| August 26, 2024 | 1.187 |
| August 23, 2024 | 1.194 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5405
Minimum
Oct 30 2023
8.774
Maximum
Jan 14 2022
1.846
Average
0.8893
Median
Price to Book Value Benchmarks
| AC Immune SA | 2.162 |
| CRISPR Therapeutics AG | 2.182 |
| Addex Therapeutics Ltd | 0.8125 |
| NLS Pharmaceutics Ltd | -- |
| MoonLake Immunotherapeutics | 5.648 |
Price to Book Value Related Metrics
| PS Ratio | 22.67 |
| Price | 6.12 |
| Earnings Yield | -32.21% |
| Market Cap | 203.08M |